Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3651861019 | Product containing caffeine and sodium benzoate (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713688017 | Caffeine- and sodium benzoate-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing caffeine and sodium benzoate (medicinal product) | est un(e) (attribut) | sodium benzoate | true | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | est un(e) (attribut) | Product containing caffeine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Stimulant (substance) | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Caffeine | true | Inferred relationship | Some | 2 | |
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Xanthine | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Bronchodilator (substance) | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Sodium benzoate | true | Inferred relationship | Some | 1 | |
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Sodium | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Phosphodiesterase inhibitor | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Xanthine | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a pour principe actif (attribut) | Sodium electrolyte | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | est un(e) (attribut) | Product containing caffeine in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing caffeine and sodium benzoate (medicinal product) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caffeine and sodium benzoate only product | est un(e) (attribut) | True | Product containing caffeine and sodium benzoate (medicinal product) | Inferred relationship | Some | |
| Caffeine and sodium benzoate injection solution vial (product) | est un(e) (attribut) | False | Product containing caffeine and sodium benzoate (medicinal product) | Inferred relationship | Some | |
| Caffeine- and sodium benzoate-containing product in parenteral dose form | est un(e) (attribut) | True | Product containing caffeine and sodium benzoate (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR